NASA, World Health Organization, and Harvard Representative to Give Keynotes at Annual Global ISPE Event
ISPE announced that it has secured Samuel Bogoch MD, PhD, Harvard Medical School and Boston University School of Medicine faculty member, Lembit Rägo MD, PhD, Coordinator of Quality Assurance and Safety for the WHO, and Antonio J. Ricco, PhD, Chief Technologist in NASA Ames Research Center’s Small Spacecraft Division to give keynote presentations at its 2009 Annual Meeting 8-11 November at the Manchester Grand Hyatt San Diego in San Diego, CA, USA.
Tampa, FL, September 03, 2009 --(PR.com)-- ISPE, a global not-for-profit association of 24,000 pharmaceutical science and manufacturing professionals, announced today that it has secured Samuel Bogoch MD, PhD, a faculty member at both Harvard Medical School and the Boston University School of Medicine, Lembit Rägo MD, PhD, Coordinator of Quality Assurance and Safety: Medicines Essential Medicines and Pharmaceutical Policies at the World Health Organization (WHO), and Antonio J. Ricco, PhD, Chief Technologist for Small Payloads and Instrumentation in NASA Ames Research Center’s Small Spacecraft Division to give keynote presentations at the ISPE 2009 Annual Meeting being held 8-11 November at the Manchester Grand Hyatt San Diego in San Diego, CA, USA.
“The Keynote Session—with its impressive list of highly respected and credentialed speakers—is just one of the many opportunities at ISPE 2009 Annual Meeting for pharmaceutical professionals to learn about emerging global industry trends and practices,” said Robert P. Best, President and CEO of ISPE. “The meeting’s content-rich education sessions also provide critical information and interaction with industry experts and regulatory authorities. This year’s theme, ‘Thriving in a Survival Environment,’ will resonate with industry professionals around the globe and is the Society’s ‘do not miss’ event of the year.”
Information About the Speakers
Samuel Bogoch MD, PhD, is chairman of Replikins, Ltd., in Boston, Massachusetts, USA, and faculty at both Harvard Medical School and the Boston University School of Medicine. Dr. Bogoch's areas of research include chemical structure and virus receptor properties of brain gangliosides, inhibition of virus attachment to brain cells, structure and function of brain glycoproteins, biochemistry of cancer, serum antibodies to cancer antigens, the replikins, genomic peptides associated with rapid replication, quantitative relation of replikins to virus outbreaks, and advance warning of H5N1.
Lembit Rägo MD, PhD, is Coordinator, Quality Assurance and Safety: Medicines Essential Medicines and Pharmaceutical Policies at the World Health Organization (WHO) in Geneva, Switzerland. In December 1999, he joined the WHO in the Department of Essential Drugs and Medicines Policy where the areas of medicine nomenclature, quality standards, regulatory guidelines, safety and pharmacovigilance, are addressed. Since 2000, he has been the WHO observer to the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) Steering Committee.
Antonio J. Ricco, PhD, is Chief Technologist for Small Payloads and Instrumentation in NASA Ames Research Center’s Small Spacecraft Division, on loan from Stanford University’s Department of Electrical Engineering and Center for Integrated Systems. At NASA, Ricco develops remote, autonomous bioanalytical systems for fundamental space biological studies; serves as chief technologist for the GeneSat, PharmaSat, and O/OREOS flight projects; and is instrument lead for the MEMS-based NIR spectrometer on the LCROSS lunar impactor. Ricco is Vice President of the Transducer Research Foundation and a member of NASA’s Lunar Exploration Analysis Group.
ISPE 2009 Annual Meeting Highlights
Education sessions at the 2009 ISPE Annual Meeting will follow 11 tracks of interest: Survival, Product Development, Facilities and Equipment, Information Systems, Supply Chain Management, Production Systems, Regulatory Compliance, Quality Systems, Investigational Products, Project Management, and Supplier-focused. Networking activities, exhibits, and special events will also allow for one-on-one time with colleagues for further knowledge and best practice sharing.
2009 Facility of the Year Award Winner Announcement. In addition to the educational offerings, the overall 2009 Facility of the Year Award winner will be announced for the first time during the Keynote Address. Category winners for 2009 are Aseptic Technologies - Equipment Innovation Winner; Centocor Biologics Ireland - Sustainability Winner; Centocor R&D Schaffhausen - Facility Integration Winner, Hameln Pharma - Operational Excellence Winner, Orchid Chemicals & Pharmaceuticals - Regional Excellence Winner, and Roche Pharma Biotech Production Basel - Project Execution Winner.
ISPE Membership and Awards Ceremony will be held 10 November, and reveal the winners of the ISPE Member of the Year, Company of the Year, Chapter or Affiliate of the Year, International Student Poster Competition winner, among many others.
Certified Pharmaceutical Industry Professional™ (CPIP™) introduction workshops will be held 9-10 November to provide information about this program and examination overview. How-to workshops will be held 9-11 November to provide information on how to submit a CPIP eligibility application and prepare for the CPIP examination.
2nd Annual COP Night will be held 9 November. ISPE’s 19 Communities of Practice (COPs) are teaming up to offer attendees an experience customized to their interests where friends and colleagues can network in a fun-filled, relaxing atmosphere.
Table Top Exhibition will be held 8-10 November to showcase products and services from the industry. For information, contact Dave Hall at +1-813-960-2105 or visit the ISPE Annual Meeting Exhibitors page.
Go to www.ISPE.org/annualmeeting or call +1-813-960-2105 for more information or to register for this premiere event.
About ISPE
ISPE, the International Society for Pharmaceutical Engineering, is the Society of choice for 24,000 pharmaceutical science and manufacturing professionals in 90 countries. ISPE aims to be the catalyst for "Engineering Pharmaceutical Innovation" by providing Members with opportunities to develop technical knowledge, exchange practical experience, and collaborate with global regulatory agencies and industry leaders. Founded in 1980, ISPE has worldwide headquarters in Tampa, Florida, USA; its European office in Brussels, Belgium; and its Asia Pacific office in Singapore. Visit www.ISPE.org for additional Society news and information.
###
“The Keynote Session—with its impressive list of highly respected and credentialed speakers—is just one of the many opportunities at ISPE 2009 Annual Meeting for pharmaceutical professionals to learn about emerging global industry trends and practices,” said Robert P. Best, President and CEO of ISPE. “The meeting’s content-rich education sessions also provide critical information and interaction with industry experts and regulatory authorities. This year’s theme, ‘Thriving in a Survival Environment,’ will resonate with industry professionals around the globe and is the Society’s ‘do not miss’ event of the year.”
Information About the Speakers
Samuel Bogoch MD, PhD, is chairman of Replikins, Ltd., in Boston, Massachusetts, USA, and faculty at both Harvard Medical School and the Boston University School of Medicine. Dr. Bogoch's areas of research include chemical structure and virus receptor properties of brain gangliosides, inhibition of virus attachment to brain cells, structure and function of brain glycoproteins, biochemistry of cancer, serum antibodies to cancer antigens, the replikins, genomic peptides associated with rapid replication, quantitative relation of replikins to virus outbreaks, and advance warning of H5N1.
Lembit Rägo MD, PhD, is Coordinator, Quality Assurance and Safety: Medicines Essential Medicines and Pharmaceutical Policies at the World Health Organization (WHO) in Geneva, Switzerland. In December 1999, he joined the WHO in the Department of Essential Drugs and Medicines Policy where the areas of medicine nomenclature, quality standards, regulatory guidelines, safety and pharmacovigilance, are addressed. Since 2000, he has been the WHO observer to the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) Steering Committee.
Antonio J. Ricco, PhD, is Chief Technologist for Small Payloads and Instrumentation in NASA Ames Research Center’s Small Spacecraft Division, on loan from Stanford University’s Department of Electrical Engineering and Center for Integrated Systems. At NASA, Ricco develops remote, autonomous bioanalytical systems for fundamental space biological studies; serves as chief technologist for the GeneSat, PharmaSat, and O/OREOS flight projects; and is instrument lead for the MEMS-based NIR spectrometer on the LCROSS lunar impactor. Ricco is Vice President of the Transducer Research Foundation and a member of NASA’s Lunar Exploration Analysis Group.
ISPE 2009 Annual Meeting Highlights
Education sessions at the 2009 ISPE Annual Meeting will follow 11 tracks of interest: Survival, Product Development, Facilities and Equipment, Information Systems, Supply Chain Management, Production Systems, Regulatory Compliance, Quality Systems, Investigational Products, Project Management, and Supplier-focused. Networking activities, exhibits, and special events will also allow for one-on-one time with colleagues for further knowledge and best practice sharing.
2009 Facility of the Year Award Winner Announcement. In addition to the educational offerings, the overall 2009 Facility of the Year Award winner will be announced for the first time during the Keynote Address. Category winners for 2009 are Aseptic Technologies - Equipment Innovation Winner; Centocor Biologics Ireland - Sustainability Winner; Centocor R&D Schaffhausen - Facility Integration Winner, Hameln Pharma - Operational Excellence Winner, Orchid Chemicals & Pharmaceuticals - Regional Excellence Winner, and Roche Pharma Biotech Production Basel - Project Execution Winner.
ISPE Membership and Awards Ceremony will be held 10 November, and reveal the winners of the ISPE Member of the Year, Company of the Year, Chapter or Affiliate of the Year, International Student Poster Competition winner, among many others.
Certified Pharmaceutical Industry Professional™ (CPIP™) introduction workshops will be held 9-10 November to provide information about this program and examination overview. How-to workshops will be held 9-11 November to provide information on how to submit a CPIP eligibility application and prepare for the CPIP examination.
2nd Annual COP Night will be held 9 November. ISPE’s 19 Communities of Practice (COPs) are teaming up to offer attendees an experience customized to their interests where friends and colleagues can network in a fun-filled, relaxing atmosphere.
Table Top Exhibition will be held 8-10 November to showcase products and services from the industry. For information, contact Dave Hall at +1-813-960-2105 or visit the ISPE Annual Meeting Exhibitors page.
Go to www.ISPE.org/annualmeeting or call +1-813-960-2105 for more information or to register for this premiere event.
About ISPE
ISPE, the International Society for Pharmaceutical Engineering, is the Society of choice for 24,000 pharmaceutical science and manufacturing professionals in 90 countries. ISPE aims to be the catalyst for "Engineering Pharmaceutical Innovation" by providing Members with opportunities to develop technical knowledge, exchange practical experience, and collaborate with global regulatory agencies and industry leaders. Founded in 1980, ISPE has worldwide headquarters in Tampa, Florida, USA; its European office in Brussels, Belgium; and its Asia Pacific office in Singapore. Visit www.ISPE.org for additional Society news and information.
###
Contact
ISPE
Marni Schribman
813-960-2105
www.ISPE.org
Marni Schribman
813-960-2105
www.ISPE.org
Contact
Categories